IRIS
MORAN, EVA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.846
Totale 2.846
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 2.846
Totale 2.846
Salva come PNG Salva come JPEG
Città #
Genova 2.154
Rapallo 384
Genoa 305
Bordighera 2
Vado Ligure 1
Totale 2.846
Salva come PNG Salva come JPEG
Nome #
Grb7 upregulation is a molecular adaptation to HER2 signaling inhibition due to removal of AKT-mediated gene repression 174
1222 POSTER Chemical Screening for Potentiators of Lapatinib Activity in Human Breast Cancer 173
Proteasome inhibitors as immunosuppressants: biological rationale and clinical experience. 156
APO866 activity in hematologic malignancies: a preclinical in vitro study. 148
Systems medicine in colorectal cancer: from a mathematical model toward a new type of clinical trial 147
Ras-induced resistance to lapatinib is overcome by MEK inhibition 143
Monoclonal antibodies for non-Hodgkin's lymphoma: state of the art and perspectives. 141
A multi-scale approach to colorectal cancer: from a biochemical- interaction signaling-network level, to multi-cellular dynamics of malignant transformation. Interplay with mutations and onco-protein inhibitor drugs. 141
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells. 139
Peripheral blood vs. bone marrow for molecular monitoring of BCR-ABL1 levels in chronic myelogenous leukemia, a retrospective analysis in allogeneic bone marrow recipients. 134
Catastrophic NAD(+) Depletion in Activated T Lymphocytes through Nampt Inhibition Reduces Demyelination and Disability in EAE 132
Molecular diagnosis and monitoring of chronic myelogenous leukemia: BCR-Abl and more. 127
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells 117
ANTITUMOR ACTIVITY OF NAMPT INHIBITION AND SYNERGY WITH CYCLOSPORIN A AND HDACIS TO PROMOTE APOPTOSIS IN PRIMARY LEUKEMIC CELLS 113
Immunotherapy with dendritic cells for cancer 109
Potent synergistic interaction between the Nampt inhibitor APO866 and the apoptosis activator TRAIL in human leukemia cells. 104
Anti-cancer activity of 5-O-alkyl 1,4-imino-1,4-dideoxyribitols. 103
Catastrophic NAD+ Depletion through Nampt Inhibition in Activated T Lymphocytes Reduces Demyelination and Disability in EAE. 94
Novel 2-[(benzylamino)methyl]pyrrolidine-3,4-diol derivatives as alpha-mannosidase inhibitors and with antitumor activities against hematological and solid malignancies. 94
Chemical Screening for Potentiators of Lapatinib Activity in Human Breast Cancer 85
Current standards and future strategies in immunochemotherapy of non-Hodgkin's lymphoma. 74
The role of proteasome in malignant diseases. 63
Depletion of the intracellular coenzyme NAD plus in activated T-cells ameliorates experimental autoimmune encephalomyelitis 58
Potent Synergistic Activity of the NAD plus Synthesis Inhibitor APO866 and of the Apoptosis Inducer TRAIL in in Vitro and Ex Vivo Cellular Models of Non Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia. 57
Selection of patients with high risk endometrial cancer for surgical staging according to the evaluation of pre- and intraoperative risk factors 43
Totale 2.869
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.025
article - articoli 7.792
book - libri 0
conference - conferenze 233
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.050
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020667 30 21 30 42 62 78 98 41 48 111 84 22
2020/2021184 16 15 9 14 27 16 14 13 14 13 15 18
2021/2022360 14 29 37 54 16 16 23 78 8 32 19 34
2022/2023468 44 59 2 60 99 56 7 25 55 1 54 6
2023/2024208 5 15 3 31 13 64 11 8 7 2 15 34
2024/202516 16 0 0 0 0 0 0 0 0 0 0 0
Totale 2.869